Naproxen is classified as a nonsteroidal anti-inflammatory dug (NSAID) and was initially approved for prescription use in 1976 and then for over-the-counter (OTC) use in 1994.[A178975] It can effectively manage acute pain as well as pain related to rheumatic diseases, and has a well studied adverse effect profile.[A179098] Given its overall tolerability and effectiveness, naproxen can be considered a first line treatment for a variety of clinical situations requiring analgesia.[A179098] Naproxen is available in both immediate and delayed release formulations, in combination with sumatriptan to treat migraines, and in combination with esomeprazole to lower the risk of developing gastric ulcers.[L6582][L6583][L7309][L7312]
Naproxen Sodium and Pseudoephedrine Hydrochloride Cold and Sinus
Equate All Day Pain Relief
Mylan-naproxen EC
Medique at Home Mediproxen
Aleve Caplets
Good Sense All Day Pain Relief
Medique Mediproxen
Naproxen Sodium and Pseudoephedrine Hydrochloride Sinus and Cold
Maxidol Liquid Gels
Naprosyn Sup 500mg
Sumatriptan and Naproxen Sodium
Equate Naproxen Sodium
Apo-naproxen
Naproxen Back and Muscle Pain
Healthy Accents Naproxen Sodium
Theraproxen-500
Naproxen Delayed Release
AnaDent
First Aid Direct Naproxen Sodium
PREVACID NapraPAC 500
Flanax
All Day Pain Relief
Naproxen Sodium Diphenhydramine HCL
Nu-napro-NA DS
Aleve PM
Cold FAid
DG Health Naproxen Sodium
Family Wellness Naproxen Sodium
Back and Muscle Pain
Equaline Naproxen Sodium PM
Flanax Pain Relief Kit
Naprosyn 250mg
Naproxen 125 Tab 125mg
Pain Zero
Proxen Np 660
EC-Naprosyn
Naproxen Sodium Back and Muscle Pain Caplets
Indication
Naproxen is indicated for the management of rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, polyarticular juvenile idiopathic arthritis, tendinitis, bursitis, acute gout, primary dysmenorrhea, and for the relief of mild to moderate pain.[L6582][L6583][A178975] Further, it is first-line therapy for osteoarthritis, acute gouty arthritis, dysmenorrhea, and musculoskeletal inflammation and pain.[A178975]
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison
T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS.
Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682